Published in Thromb Res on December 15, 1986
Protective effect of Tulbaghia violacea Harv. on aortic pathology, tissue antioxidant enzymes and liver damage in diet-induced atherosclerotic rats. Int J Mol Sci (2012) 0.78
Pharmacodynamic interaction study of Allium sativum (garlic) with cilostazol in patients with type II diabetes mellitus. Indian J Pharmacol (2011) 0.75
Sustained release of epidermal growth factor accelerates wound repair. Proc Natl Acad Sci U S A (1985) 1.66
Monospecific antibodies implicate basic fibroblast growth factor in normal wound repair. Lab Invest (1989) 1.48
Accelerated wound repair, cell proliferation, and collagen accumulation are produced by a cartilage-derived growth factor. J Cell Biol (1985) 1.41
Recombinant basic fibroblast growth factor accelerates wound healing. J Surg Res (1988) 1.29
The intracellular degradation of poly(epsilon-caprolactone). J Biomed Mater Res (1985) 1.17
Stimulation of fibroplasia by vitamin A. Surg Forum (1969) 1.09
The endothelium: roles in thrombosis and hemostasis. Arch Pathol Lab Med (1977) 1.00
Sustained microgravity reduces intrinsic wound healing and growth factor responses in the rat. FASEB J (1999) 0.99
Differential stimulation of collagenase and chemotactic activity in fibroblasts derived from rat wound repair tissue and human skin by growth factors. J Cell Physiol (1989) 0.98
The diabetic rat as an impaired wound healing model: stimulatory effects of transforming growth factor-beta and basic fibroblast growth factor. Biotechnol Ther (1993) 0.97
Can breast carcinoma be anticipated? A follow-up of benign breast biopsies. Ann Surg (1968) 0.94
Reduced NFAT1 protein expression in human umbilical cord blood T lymphocytes. Blood (1999) 0.94
Scaling of hemolysis in needles and catheters. Ann Biomed Eng (1998) 0.94
Epidermal growth factor increases granulation tissue formation dose dependently. J Surg Res (1987) 0.92
Urinary bladder calculus formation on sutures in rabbits, cats and dogs. Surg Gynecol Obstet (1978) 0.91
How fibroblasts and giant cells encapsulate implants: considerations in design of glucose sensors. Diabetes Care (1983) 0.91
Effects of heparin on platelet aggregation and release and thromboxane A2 production. Am J Pathol (1981) 0.88
Stimulation of fibroplasia in rats by bovine cartilage powder. Arch Surg (1968) 0.88
Thromboembolization associated with sudden increases in flow in a coronary stent ex vivo shunt model. ASAIO J (2000) 0.87
Prostacyclin production following in vitro mixing of normal with hemolytic-uremic-syndrome serum. West J Med (1988) 0.86
Characterization of human platelets separated from blood by ADP-induced aggregation. Am J Pathol (1975) 0.86
An experimental study of wound healing accelerators. Am Surg (1972) 0.86
Inhibition of human platelet-collagen adhesion reaction by amitriptyline and imipramine. Proc Soc Exp Biol Med (1974) 0.85
In vitro investigation of thrombogenesis in rotary blood pumps. Artif Organs (1993) 0.84
Adhesion of human blood platelets to glass and polymer surfaces. I. Studies with platelets in plasma. Haemostasis (1974) 0.84
Anaerobic threshold in total artificial heart animals. ASAIO J (1996) 0.84
Recombinant transforming growth factor beta accelerates incisional wound healing. Curr Surg (1989) 0.84
Erroneous test results obtained with the Tandem-E TSH kit. Clin Chem (1988) 0.84
In vitro prostacyclin production in the hemolytic-uremic syndrome. West J Med (1986) 0.83
Growth factors bFGF and TGB beta accelerate the rate of wound repair in normal and in diabetic rats. Int J Tissue React (1988) 0.82
Adhesion of human blood platelets to glass polymer surfaces. II. Demonstration of the presence of a natural platelet adhesion inhibitor in plasma and serum. Haemostasis (1976) 0.82
The adhesion of platelets to subendothelium, collagen and artifilial surfaces. Semin Thromb Hemost (1976) 0.82
Heparin potentiates synthesis of thromboxane A2 in human platelets. Adv Prostaglandin Thromboxane Res (1980) 0.82
Pancreatic one-carbon metabolism in early folate deficiency in rats. Am J Clin Nutr (1993) 0.82
Acute phase vascular endothelial injury: a comparison of temporary arterial occlusion using an endovascular occlusive balloon catheter versus a temporary aneurysm clip in a pig model. Neurosurgery (1994) 0.81
The role of plasma proteins in formation of obstructive protamine complexes. J Cardiothorac Vasc Anesth (1991) 0.81
Specific inhibition of platelet agglutination and aggregation by aromatic amidino compounds. Thromb Haemost (1978) 0.81
Spreadsheet templates for calculating precision according to NCCLS (National Committee for Clinical Laboratory Standards) guidelines. MLO Med Lab Obs (1993) 0.79
An in-vitro model to study device-induced thrombosis and embolism: evaluation of the efficacy of tirofiban, aspirin, and dipyridamole. Thromb Haemost (2000) 0.79
Blood compatibility of PEO grafted polyurethane and HEMA/styrene block copolymer surfaces. J Biomed Mater Res (1990) 0.78
Albumin-IgG complexes in human serum and plasma that inhibit blood platelet adhesion. Proc Natl Acad Sci U S A (1981) 0.78
Effect of heparin on platelet aggregation inhibited by PGI2, trifluoperazine and verapamil. Thromb Res (1986) 0.78
In vitro investigation of the St. Jude Medical Isoflow centrifugal pump: flow visualization and hemolysis studies. Artif Organs (1997) 0.78
A comparison of the antiplatelet effect of aspirin on human and bovine platelets. ASAIO Trans (1990) 0.78
The influence of harvesting technique on endothelial preservation in saphenous veins. J Surg Res (1992) 0.77
The influences of sample distribution and age on reference intervals for adult males. Am J Clin Pathol (1983) 0.77
Involvement of fibrinogen in protamine-induced pulmonary hypertension. J Surg Res (1997) 0.77
Fibrinogen fragments and platelet dysfunction in uremia. Kidney Int (1999) 0.77
Effects of plasma on adhesion of biofilm forming Pseudomonas aeruginosa and Staphylococcus epidermidis to fibrin substrate. ASAIO J (1997) 0.77
Heparin removal from blood using poly(L-lysine) immobilized hollow fiber. Biotechnol Bioeng (1992) 0.77
Ketanserin prevents platelet aggregation and endotoxin-induced pulmonary vasoconstriction. Crit Care Med (1983) 0.77
Endothelium: newly discovered functions and methods of study. J Bioeng (1976) 0.76
111Indium labeling of microorganisms to facilitate the investigation of bacterial adhesion. J Biomed Mater Res (1993) 0.76
Experimental vitreous fibroplasia following perforating ocular injuries. Arch Ophthalmol (1979) 0.76
Effects of antithrombotic agents evaluated in a nonhuman primate vascular shunt model. Am J Pathol (1976) 0.75
An in vitro test model to study the performance and thrombogenicity of cardiovascular devices. ASAIO Trans (1990) 0.75
Roles of polymer size and epsilon-amino groups in polylysine-platelet interaction. Thromb Res (1977) 0.75
The effects of a fluoroalkyl cyanoacrylate tissue adhesive upon granulation tissue development, fibrioplasia and hemostasis. Am Surg (1970) 0.75
Acute hematologic response of sheep to cardiopulmonary bypass and total heart replacement. Trans Am Soc Artif Intern Organs (1984) 0.75
Comparison of methods for determining biodegradability of cyanoacrylate tissue adhesives. Res Commun Chem Pathol Pharmacol (1972) 0.75
Reduced platelet adhesion and activation of coagulation factors on polyurethane treated with albumin-IgG complex. ASAIO Trans (1987) 0.75
Experimental anastomoses of small arteries employing alkyl-cyanoacrylates. J Biomed Mater Res (1967) 0.75
A human model for study of blood-vascular wall interactions. Effects of enzymatic treatment of intima. Arch Pathol Lab Med (1981) 0.75
Blood components deposited on used and reused dialysis membranes. Biomater Med Devices Artif Organs (1976) 0.75
A concise method for study of the binding of thrombin to human platelets. Res Commun Chem Pathol Pharmacol (1977) 0.75
The effects of aprotonin on platelets in vitro using whole blood flow cytometry. Anesth Analg (2000) 0.75
Physiological and biochemical evaluation of implanted polymers. Ann N Y Acad Sci (1968) 0.75
Isolation and partial purification of an activity from human pulmonary epidermoid carcinoma cells in culture that clots heparinized plasma. Prog Clin Biol Res (1982) 0.75
Quantitative removal of heparin from plasma and other aqueous solutions by affinity adsorption on poly(L-lysine)-sepharose 4B. Thromb Res (1981) 0.75
Functions of endothelium. Pathobiol Annu (1979) 0.75
Adsorption and reactivity of human fibrinogen and immunoglobulin G on two types of hemodialysis membranes. Int J Artif Organs (1983) 0.75
Induction and reversal of pulmonary lipid histiocytosis in rats following oral administration of anorectics cloforex and chlorphentermine. J Toxicol Environ Health (1981) 0.75
Disulfide linking of albumin to the hinge region of immunoglobulin G in normal human serum. Biochim Biophys Acta (1983) 0.75
Interactions of thrombin and antithrombin III with artificial surfaces. Thromb Res (1979) 0.75
Prostacyclin (PGI2) inhibits the enhancement of granulocyte adhesion to Cuprophane induced by immunoglobulin G. Thromb Res (1981) 0.75
The effects of heparin, protamine, and heparinase 1 on platelets in vitro using whole blood flow cytometry. Anesth Analg (2000) 0.75
Device induced thromboembolism in a bovine in vitro coronary stent model. ASAIO J (1999) 0.75
A human model for study of blood-vascular wall interactions. I. Description and demonstration of use of the model. Arch Surg (1980) 0.75
Recurrence of colon carcinoma after curative resection and blood transfusion: proposal for a prospective study. Transplant Proc (1988) 0.75
Isolation and some of the physicochemical and immunologic properties of a platelet adhesion inhibitor from human serum. Thromb Res (1980) 0.75
Photoelectric technique for estimating plasma coagulation time. Nature (1967) 0.75
Pulmonary artery to pulmonary artery shunt (PAPAS). Trans Am Soc Artif Intern Organs (1985) 0.75
Test systems for evaluation of cyanoacrylate tissue adhesives. J Biomed Mater Res (1970) 0.75
Elastin breakdown and regeneration in emphysema. Hum Pathol (1989) 0.75
The effect of cyanoacrylate tissue adhesives upon granulation tissue formation in Ivalon sponge implants in the rat. Surgery (1966) 0.75
Formation of occlusive platelet aggregates in whole blood caused by low concentrations of ADP. ASAIO J (2001) 0.75
Spreadsheet templates for calculating linearity according to EP6-P. MLO Med Lab Obs (1992) 0.75
Interaction of human alpha-thrombin with artificial surfaces and reactivity of adsorbed alpha-thrombin. J Biomed Mater Res (1980) 0.75
Study of platelet function in a calf with artificial ventricles attached to an ex vivo shunt. ASAIO Trans (1987) 0.75
Affinity chromatographic demonstration of a thrombin binding protein from the platelet plasma membrane. Res Commun Chem Pathol Pharmacol (1978) 0.75
Pulsatile augmentation device for extracorporeal circulation. Artif Organs (1996) 0.75
Blood mercury concentration in an urban population. Sci Total Environ (1977) 0.75
Interactions of poly (L-lysine) with human platelets. Correlation of binding with induction of platelet aggregation. Thromb Res (1979) 0.75
Intrauterine rhythm and blues? Br J Obstet Gynaecol (1992) 0.75
Isolation and physicochemical and immunologic characterization of human platelet factor 3. Thromb Res (1979) 0.75
The light-scattering whole blood aggregometer: a novel device for assessment of platelet aggregation in undiluted blood. Arch Pathol Lab Med (1998) 0.75
Three sigma revisited. Bayes' theorem and quality control. Arch Pathol (1968) 0.75
Mineralization of connective tissue surrounding implanted devices. Trans Am Soc Artif Intern Organs (1981) 0.75